Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis

Recruiting now · Not applicable

Conditions studied: TUBERCULOSIS

In brief

Methodology This is a single-center study carried out as part of routine patient care. The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.

Key facts

Study ID

NCT06485895

Run by

Assistance Publique Hopitaux De Marseille

People needed

500

Starts

2024-07-30

Expected to finish

2028-02-01

Last updated by the study team

2024-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individual at least 18 years of age
• Patient presenting for treatment of tuberculosis disease
• Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test.
• Informed patient who has not expressed opposition to participating in the study.
• French-speaking patient with unambiguous understanding of oral and written instructions.

You may not qualify if…

• Persons in a period of exclusion from another study
• Pregnant, parturient or breast-feeding women;
• Person deprived of liberty by judicial or administrative decision

Where it is running

• Assistance Publique Hopitaux de Marseille — Marseille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.